RALPH DOMINGO: Open Payments
NPI 1528706207 · WAILUKU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,114 in 42 payments from 11 companies in 2025. Trend: 2023 $577 · 2024 $337 · 2025 $1,114
Food & beverage: $1,114
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $251 |
| Novo Nordisk Inc | 10 | $223 |
| Amgen Inc. | 8 | $152 |
| ABBVIE INC. | 2 | $135 |
| INTUITIVE SURGICAL, INC. | 1 | $117 |
| AstraZeneca Pharmaceuticals LP | 4 | $93 |
| Lilly USA, LLC | 2 | $41 |
| GENZYME CORPORATION | 1 | $34 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| SANOFI PASTEUR INC. | 1 | $25 |
Products named: NUCALA, Da Vinci Surgical System, QULIPTA, Ozempic, KRYSTEXXA, OTEZLA, Rybelsus, Wegovy.
Industry payments across HI — which companies pay providers there.
